The Cefotaxime for Injection,usp, cataloged under National Stock Number 6505-01-524-9732, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Hikma Pharmaceuticals Usa Inc.. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-524-9732 |
| Primary Part Number | NDC00143-9931-25 |
| Item Name | Cefotaxime for Injection,usp |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Hikma Pharmaceuticals Usa Inc. |
| Status | ACTIVE |
| American Hospital Formulary Service Classification Number | 081206 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00143-9931-25 PRIMARY | Hikma Pharmaceuticals Usa Inc. (USA) |
| Reference | Meaning |
|---|---|
| 04-1471 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-524-9732 is a Cefotaxime for Injection,usp, manufactured by Hikma Pharmaceuticals Usa Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-524-9732 has 1 manufacturer part number on file: NDC00143-9931-25 (Hikma Pharmaceuticals Usa Inc.).
Key specifications for NDC00143-9931-25: Special Features: ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1 GM CEFOTAXIME EQUIVALENT; ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS: PRIMARY CONTAINER TYPE: VIAL SINGLE DOSE; PRIMARY CONTAINER CONTENT QUANITY: 10 ML; TOTAL PRIMARY CONTAINER QUANITITY 25 FEATURE PROVIDED: STERILE; CEFOTAXIME IS INDICATED FOR THE TREATMENT OF PATIENTS WITH SERIOUS INFECTION CAUSED BY SUSCEPTIBLE STRAINS OF THE DESIGNATED MICROOGRANISMS IN THE LOWER RESPIRATORY TRACT, GENITOURINARY INFECTIONS, GYNECOLOGIC INFECTIONS, BACTEREMIA/SEPTICEMIA, SKIN AND SKIN STRUCTURE INFECTIONS, INTRA-ABDOMINAL INFECTIONS, BONE AND JOINT INFECTIONS, AND CENTRAL NERVOUS SYSTEM INFECTIONS; STORE AT CONTROLLED ROOM TEMPERATURE; Part Name Assigned by Controlling Agency: CEFOTAXIME FOR INJECTION USP 1 GM EQUIVALENT 10 ML (25) SINGLE DOSE VIALS PER PACKAGE; American Hospital Formulary Service Classification Number: 081206. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.